Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
Date:10/12/2008

SEATTLE, Oct. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) has been selected to present at three upcoming investor conferences. The conferences include the 7th Annual BIO Investor Forum in San Francisco in October, the 19th Annual Oppenheimer & Co. Healthcare Conference, and the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference in November, both in New York City.

The presentations will be webcast live with slides, and available for replay after the presentation at http://www.celltherapeutics.com.

BIO Investor Forum

CTI Presentation: Thursday, October 30, 2008

8:00 AM PT/11:00 AM ET/4:00 PM CET

Room TBA, Palace Hotel, San Francisco

Oppenheimer & Co. Healthcare Conference

CTI Presentation: Monday, November 3, 2008

8:00 AM ET/2:00 PM CET/5:00 AM PT

Astor Room, Waldorf-Astoria Hotel, New York City

Acumen BioFin Rodman & Renshaw Healthcare Conference

CTI Presentation: Tuesday, November 11, 2008

10:45 AM EST/4:45 PM CET/7:45 AM PST

Kennedy I, New York Palace Hotel, New York City

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Ed Bell

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 Lindsey Jesch Logan

E: media@ctiseattle.com T: 206.272.4347

http://www.celltherapeutics.com/press_room F: 206.272.4434

http://www.celltherapeutics.com/investors E: invest@ctiseattle.com


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
2. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
6. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
7. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
8. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
9. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
10. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
11. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... Michael Fitzmaurice recently became double board-certified in surgery and surgery of the hand ... Dr. Fitzmaurice is no stranger to going above and beyond in his pursuit ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Scientists at ... line options being tried for mesothelioma may be hampering the research that could lead ... research. Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... ... 25, 2016 , ... Lady had been battling arthritis since the age of ... left knee. Lady’s owner Hannah sought the help of Dr Jeff Christiansen of ... her cruciate ligament and help with the pain of Lady’s arthritis. Dr Christiansen suggested ...
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a range ... by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method ... , The novel method, developed by WPI faculty members Raymond Page, PhD, professor ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):